Stress activates the hypothalamic–pituitary–adrenal (HPA) axis, which then modulates the
degree of adaptation and response to a later stressor. It is known that early-life stress can …

Glucocorticoids (GCs) are commonly used at high doses and for prolonged periods (weeks
to months) in the treatment of a variety of diseases. Among the many side effects are …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the global obesity
and metabolic disease epidemic and is rapidly becoming the leading cause of liver cirrhosis …

Background: Obesity is often associated with nonalcoholic fatty liver disease (NAFLD),
which refers to a large spectrum of hepatic lesions including fatty liver, nonalcoholic …

Glucocorticoids regulate a remarkable variety of essential functions, including development,
immunomodulation, maintenance of circadian rhythm and the response to stress …

Obesity is commonly associated with nonalcoholic fatty liver (NAFL), a benign condition
characterized by hepatic lipid accumulation. However, NAFL can progress in some patients …

Background: Diet plays a key role in the development of non-alcoholic fatty liver disease
(NAFLD). The aim of this study was to review systematically observational studies available …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
and may progress to cirrhosis or even hepatocellular carcinoma. A number of steroid …

Emerging data have highlighted the co-existence of non-alcoholic fatty liver disease
(NAFLD) and inflammatory bowel disease; both of which are increasingly prevalent …

Liver disease has become a leading cause of death, particularly in the West, where it is
attributed to more than two million deaths annually. The correlation between gut microbiota …